Results 11 to 20 of about 17,102 (166)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women

open access: yesBiomedicines, 2023
In this study, we compared the failure rates of fosfomycin and nitrofurantoin for uncomplicated urinary tract infections. We used Meuhedet Health Services’ large database to collect data on all female patients, older than 18 years, who were prescribed ...
Asher Shafrir   +3 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by Trypanosoma congolense Infection

open access: yesPathogens, 2022
Animal African trypanosomosis (AAT) leads to emaciation and low productivity in infected animals. Only six drugs are commercially available against AAT; they have severe side effects and face parasite resistance.
Keisuke Suganuma   +7 more
doaj   +1 more source

A Combination of Virtual and Experimental Screening Tools for the Prediction of Nitrofurantoin Multicomponent Crystals with Pyridine Derivatives

open access: yesCrystals, 2023
Thirty-four binary systems of nitrofurantoin with pyridine derivatives were analyzed by combining virtual (molecular complementarity prediction and hydrogen bond propensity calculations) and experimental (liquid-assisted grinding) screening methods.
Alex N. Manin   +5 more
doaj   +1 more source

Nitrofurantoin-induced interstitial lung disease

open access: yesJournal of Clinical and Scientific Research, 2022
We report the case of a 55-year-old woman diagnosed with interstitial lung disease due to long-term nitrofurantoin therapy that was administered for recurrent urinary tract infection.
Mohammed Salman   +3 more
doaj   +1 more source

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples

open access: yesAntibiotics, 2020
Fosfomycin and nitrofurantoin are antibiotics of choice to orally treat non-complicated urinary tract infections (UTIs) of community origin because they remain active against bacteria resistant to other antibiotics.
Antonio Sorlozano-Puerto   +4 more
doaj   +1 more source

Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans

open access: yesPharmaceutics, 2023
Nitrofurantoin (NFT) is a commonly used antibiotic for the treatment of urinary tract infections that can cause liver toxicity. Despite reports of hepatic adverse events associated with NFT exposure, there is still limited understanding of the interplay ...
Raju Prasad Sharma   +2 more
doaj   +1 more source

High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City

open access: yesJournal of Infection in Developing Countries, 2008
Background : The prevalence of antimicrobial resistance among uropathogenic E. coli varies widely worldwide; to guide empirical therapy is necessary to have local, up-to-date susceptibility data.
Jose Luis Arredondo-García   +1 more
doaj   +1 more source

Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient

open access: yesUrological Science, 2016
Purpose: To review the current literature on reported pulmonary, liver, and nerve adverse reactions (ARs) of long-term Nitrofurantoin (NF) suppression in older patients treated for urinary tract infections (UTIs).
Lauren L. Rego   +2 more
doaj   +1 more source

Nitrofurantoin susceptibility profile versus other antibiotics tested in uropathogens- a retrospective study from India

open access: yesMicrobes, Infection and Chemotherapy
Introduction. Urinary Tract Infection (UTI) is one of the most common bacterial infections encountered by clinicians worldwide. The emergence of multidrug-resistant uropathogens necessitates a review of their susceptibility profiles.
Anuja Gupta, Bhawna KUNAL
doaj   +1 more source

Home - About - Disclaimer - Privacy